India’s Strides buys U.S.-approved drug making plant
(Reuters) – Indian drugmaker Strides Arcolab said its unit acquired a U.S. compliant sterile drugs manufacturing plant for 1.25 billion rupees ($23.76 million), a move aimed at expediting commercialization of new products. The plant, acquired from Star Drugs and Research Labs, can make up to 97 million vials every year, it said. Shipments to the United States from the new plant will begin from the third quarter of 2012. …